AlphaDIA Transforms Proteomics with AI-Powered Data Analysis
Revolutionizing Proteomic Data Processing In a significant breakthrough for biotechnology and analytical science, researchers have developed AlphaDIA, an innovative framework…
Revolutionizing Proteomic Data Processing In a significant breakthrough for biotechnology and analytical science, researchers have developed AlphaDIA, an innovative framework…
Researchers have demonstrated a new epigenetic editing approach that provides durable gene silencing in primary human T cells without causing DNA damage. The technology, called CRISPRoff, maintains gene repression through multiple cell divisions and shows minimal cellular toxicity compared to traditional CRISPR-Cas9 methods. This breakthrough could significantly advance cell therapy development and genetic research applications.
Scientists have developed a groundbreaking epigenetic editing technology that can permanently silence genes in human immune cells without altering the underlying DNA sequence, according to research published in Nature Biotechnology. The approach, reportedly called CRISPRoff, enables durable gene repression that persists through approximately 30-80 cell divisions, representing a significant advancement over previous temporary gene silencing methods.
The New South Wales government has reached an in-principle agreement to purchase the Northern Beaches Hospital for $190 million, according to reports. The acquisition would end a decade of private operation and integrate the facility into the public hospital system, though medical staff express concerns about reduced patient choice.
The New South Wales government will reportedly spend $190 million to acquire the Northern Beaches Hospital from private operators, according to sources familiar with the agreement. The purchase would mark the end of a decade-long experiment with private ownership of a major Sydney healthcare facility and integrate it fully into the public hospital system.
Chemo Brain: The Hidden Neurological Side Effect of Cancer Treatment For millions of cancer survivors, the end of treatment doesn’t…
Bridging Machine Learning and Physical Laws in Drug Discovery In the rapidly evolving field of AI-driven drug discovery, researchers are…
New Research Reveals Metabolic Control Mechanism in Treatment-Resistant Breast Cancer A groundbreaking study published in Communications Biology has uncovered a…
The New Frontier in Pharmaceutical Innovation Artificial intelligence has emerged as a transformative force in biotechnology and digital medicine, fundamentally…
Bridging Genetic Diversity and Drug Response Through Machine Learning In a groundbreaking development for precision medicine in infectious diseases, researchers…
Breakthrough in Vision Restoration Scientists have achieved a remarkable milestone in ophthalmology with the development of a retinal implant that…
Jana Partners Builds Position in Medical Device Maker Activist investor Jana Partners has taken a significant position in Cooper Companies…